OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 114 filers reported holding OCULAR THERAPEUTIX INC in Q3 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,915,714 | -39.4% | 610,100 | -2.6% | 0.02% | -37.0% |
| Q2 2023 | $3,159,550 | -0.3% | 626,250 | +4.2% | 0.03% | -3.6% |
| Q1 2023 | $3,168,061 | +89.4% | 601,150 | +1.0% | 0.03% | +75.0% |
| Q4 2022 | $1,672,512 | -33.4% | 595,200 | -2.4% | 0.02% | -68.0% |
| Q3 2022 | $2,512,000 | +4.3% | 609,550 | +1.7% | 0.05% | +31.6% |
| Q2 2022 | $2,409,000 | -14.1% | 599,150 | +5.7% | 0.04% | -5.0% |
| Q1 2022 | $2,805,000 | -21.2% | 566,750 | +9.5% | 0.04% | -21.6% |
| Q4 2021 | $3,558,000 | -17.7% | 517,750 | +19.8% | 0.05% | -26.1% |
| Q3 2021 | $4,321,000 | – | 432,100 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
| Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
| DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
| Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
| Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
| Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
| Covestor Ltd | 60,008 | $316 | 0.28% |
| Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
| EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
| Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |